These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects. Ahmad F, Considine RV, Goldstein BJ. J Clin Invest; 1995 Jun; 95(6):2806-12. PubMed ID: 7769120 [Abstract] [Full Text] [Related]
3. Depot-specific variation in protein-tyrosine phosphatase activities in human omental and subcutaneous adipose tissue: a potential contribution to differential insulin sensitivity. Wu X, Hoffstedt J, Deeb W, Singh R, Sedkova N, Zilbering A, Zhu L, Park PK, Arner P, Goldstein BJ. J Clin Endocrinol Metab; 2001 Dec; 86(12):5973-80. PubMed ID: 11739472 [Abstract] [Full Text] [Related]
5. Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes. Ahmad F, Azevedo JL, Cortright R, Dohm GL, Goldstein BJ. J Clin Invest; 1997 Jul 15; 100(2):449-58. PubMed ID: 9218523 [Abstract] [Full Text] [Related]
6. Protein-tyrosine phosphatase activity in human adipocytes is strongly correlated with insulin-stimulated glucose uptake and is a target of insulin-induced oxidative inhibition. Wu X, Hardy VE, Joseph JI, Jabbour S, Mahadev K, Zhu L, Goldstein BJ. Metabolism; 2003 Jun 15; 52(6):705-12. PubMed ID: 12800095 [Abstract] [Full Text] [Related]
7. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases. Ahmad F, Goldstein BJ. J Cell Biochem; 1997 Jan 15; 64(1):117-27. PubMed ID: 9015760 [Abstract] [Full Text] [Related]
8. Increased abundance of specific skeletal muscle protein-tyrosine phosphatases in a genetic model of insulin-resistant obesity and diabetes mellitus. Ahmad F, Goldstein BJ. Metabolism; 1995 Sep 15; 44(9):1175-84. PubMed ID: 7666792 [Abstract] [Full Text] [Related]
9. Protein tyrosine phosphatase 1B reduction regulates adiposity and expression of genes involved in lipogenesis. Rondinone CM, Trevillyan JM, Clampit J, Gum RJ, Berg C, Kroeger P, Frost L, Zinker BA, Reilly R, Ulrich R, Butler M, Monia BP, Jirousek MR, Waring JF. Diabetes; 2002 Aug 15; 51(8):2405-11. PubMed ID: 12145151 [Abstract] [Full Text] [Related]
10. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. J Clin Invest; 1995 May 15; 95(5):2111-9. PubMed ID: 7738178 [Abstract] [Full Text] [Related]
11. The blunted effect of glucose-dependent insulinotropic polypeptide in subcutaneous abdominal adipose tissue in obese subjects is partly reversed by weight loss. Asmar M, Arngrim N, Simonsen L, Asmar A, Nordby P, Holst JJ, Bülow J. Nutr Diabetes; 2016 May 02; 6(5):e208. PubMed ID: 27136446 [Abstract] [Full Text] [Related]
12. Adipose tissue morphology predicts improved insulin sensitivity following moderate or pronounced weight loss. Eriksson-Hogling D, Andersson DP, Bäckdahl J, Hoffstedt J, Rössner S, Thorell A, Arner E, Arner P, Rydén M. Int J Obes (Lond); 2015 Jun 02; 39(6):893-8. PubMed ID: 25666530 [Abstract] [Full Text] [Related]
13. Skeletal muscle protein tyrosine phosphatase activity and tyrosine phosphatase 1B protein content are associated with insulin action and resistance. Kusari J, Kenner KA, Suh KI, Hill DE, Henry RR. J Clin Invest; 1994 Mar 02; 93(3):1156-62. PubMed ID: 8132755 [Abstract] [Full Text] [Related]
14. Changes in abdominal subcutaneous fat water content with rapid weight loss and long-term weight maintenance in abdominally obese men and women. Laaksonen DE, Nuutinen J, Lahtinen T, Rissanen A, Niskanen LK. Int J Obes Relat Metab Disord; 2003 Jun 02; 27(6):677-83. PubMed ID: 12833111 [Abstract] [Full Text] [Related]
15. Marked impairment of protein tyrosine phosphatase 1B activity in adipose tissue of obese subjects with and without type 2 diabetes mellitus. Cheung A, Kusari J, Jansen D, Bandyopadhyay D, Kusari A, Bryer-Ash M. J Lab Clin Med; 1999 Aug 02; 134(2):115-23. PubMed ID: 10444024 [Abstract] [Full Text] [Related]
16. Protein tyrosine phosphatase activity in insulin-resistant rodent Psammomys obesus. Meyerovitch J, Balta Y, Ziv E, Sack J, Shafrir E. Int J Exp Diabetes Res; 2002 Aug 02; 3(3):199-204. PubMed ID: 12458662 [Abstract] [Full Text] [Related]
17. Effects of weight loss in obese subjects with normal fasting plasma glucose or impaired glucose tolerance on insulin release and insulin resistance according to a minimal model analysis. Yoshida Y, Hashimoto N, Tokuyama Y, Kitagawa H, Takahashi K, Yagui K, Kanatsuka A, Bujo H, Higurashi M, Miyazawa S, Yoshida S, Saito Y. Metabolism; 2004 Sep 02; 53(9):1095-100. PubMed ID: 15334366 [Abstract] [Full Text] [Related]
18. Role of cAMP in mediating effects of fasting on dephosphorylation of insulin receptor. Begum N, Graham AL, Sussman KE, Draznin B. Am J Physiol; 1992 Feb 02; 262(2 Pt 1):E142-9. PubMed ID: 1311506 [Abstract] [Full Text] [Related]
19. Body fat mass and the proportion of very large adipocytes in pregnant women are associated with gestational insulin resistance. Svensson H, Wetterling L, Bosaeus M, Odén B, Odén A, Jennische E, Edén S, Holmäng A, Lönn M. Int J Obes (Lond); 2016 Apr 02; 40(4):646-53. PubMed ID: 26563815 [Abstract] [Full Text] [Related]
20. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss. Havel PJ, Kasim-Karakas S, Mueller W, Johnson PR, Gingerich RL, Stern JS. J Clin Endocrinol Metab; 1996 Dec 02; 81(12):4406-13. PubMed ID: 8954050 [Abstract] [Full Text] [Related] Page: [Next] [New Search]